Mackenzie Financial’s Emergent Biosolutions EBS Stock Holding History

Mackenzie Financial’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817K	Buy	+97,512	New	+$816K	﹤0.01%	1220
2021 Q4	–	Sell	-4,621	Closed	-$231K	–	1453
2021 Q3	$231K	Buy	4,621 +1,004	+28%	+$60.8K	﹤0.01%	1247
2021 Q2	$228K	Buy	+3,617	New	+$232K	﹤0.01%	1137
2019 Q3	–	Sell	-4,820	Closed	-$233K	–	1031
2019 Q2	$233K	Sell	4,820 -900	-16%	-$43.1K	﹤0.01%	1008
2019 Q1	$289K	Buy	+5,720	New	+$337K	﹤0.01%	1114
2018 Q3	–	Sell	-119,689	Closed	-$6.04M	–	1114
2018 Q2	$6.04M	Sell	119,689 -600	-0.5%	-$31.3K	0.02%	411
2018 Q1	$6.33M	Buy	+120,289	New	+$6M	0.02%	397
2016 Q3	–	Sell	-27,342	Closed	-$769K	–	711
2016 Q2	$769K	Buy	+27,342	New	+$1.07M	﹤0.01%	666

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Mackenzie Financial's EBS Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 97,512 shares worth $817K. The stake represents ﹤0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in EBS as recently as Q3 2021.

Mackenzie Financial first reported a position in EBS in Q2 2016 and has held it in 8 quarters since. The position peaked at $6.33M in Q1 2018. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Mackenzie Financial held 97,512 shares of Emergent Biosolutions worth $817K as of Q2 2026.
Emergent Biosolutions was a new Mackenzie Financial position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1220 holding.
Mackenzie Financial first reported a position in Emergent Biosolutions in Q2 2016 and has held it in 8 quarters since.
Mackenzie Financial's Emergent Biosolutions position peaked at $6.33M in Q1 2018.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.